CS logo
small CS logo
Bascom Palmer Eye Institute

Palm Beach Gardens, Florida, United States
Medical clinic in Palm Beach Gardens, Florida
7101 Fairway Dr, Palm Beach Gardens, FL 33418

About Bascom Palmer Eye Institute


"The University of Miami Health System combines patient care, research, and education to create a front-line approach to health care."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Bascom Palmer Eye Institute


During the past decade, Bascom Palmer Eye Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Bascom Palmer Eye Institute" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Chicago Center for Vision Research" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

Clinical Trials Conditions at Bascom Palmer Eye Institute


According to Clinical.Site data, the most researched conditions in "Bascom Palmer Eye Institute" are "Geographic Atrophy" (3 trials), "Age-related Macular Degeneration" (1 trials), "Diabetic Macular Edema" (1 trials), "Eye Infections, Bacterial" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Bascom Palmer Eye Institute" in a lesser frequency.

Clinical Trials Intervention Types at Bascom Palmer Eye Institute


Most popular intervention types in "Bascom Palmer Eye Institute" are "Drug" (8 trials), "Other" (3 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (2 trials), "Sham Procedure" (2 trials), "ADX-2191 (intravitreal methotrexate 0.8%)" (1 trials), "APL-2" (1 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Bascom Palmer Eye Institute


The vast majority of trials in "Bascom Palmer Eye Institute" are 9 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Bascom Palmer Eye Institute


Currently, there are NaN active trials in "Bascom Palmer Eye Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bascom Palmer Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Bascom Palmer Eye Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".